DOSSIER · 13F-HR · Q2 2026

NVP Associates, LLC

$328M in tracked AUM across 7 positions as of Q2 2026.

NA
CIK 0001545692 · last filed Jun 30, 2026
Total AUM
$328M
as of Q2 2026
Holdings
7
positions
Whale Score
71
71
strong
Activity
no data
changes this Q
AI Analysis · Q2 2026

Portfolio Overview

NVP Associates, LLC presents a highly concentrated, high-conviction investment portfolio characterized by low turnover and significant exposure to small-cap and micro-cap growth companies. As of the reporting period ending September 30, 2025, the firm managed approximately $166.05 million across just 5 holdings. The portfolio experienced a decrease in value of 9.8% (down from $184.15 million in the previous quarter), a decline driven by a combination of market...

The portfolio structure is extremely top-heavy, with the top three holdings—Omada Health, Zenas Biopharma, and MBX Biosciences—accounting for approximately 80.8% of the total assets. This lack of broad diversification suggests an investment philosophy that prioritizes specific stock selection over broad market exposure or risk mitigation through sector spreading. The firm appears to operate as a specialized investor willing to take outsized risks on a select few companies.

Key Holdings

Analysis generated by 13F Insight from SEC Form 13F filing data · Q2 2026. Methodology

Quarter at a glance — Q2 2026

Position-change comparison pending.

No quarter-over-quarter changes available.

Top 10 holdings

By portfolio weight as of Q2 2026.

#HoldingValueSharesWeight
01
MBX
MBX BIOSCIENCES INC
$118M2.1M35.9%
02
AVLN
AVALYN PHARMACEUTICALS INC
$75M2.3M22.8%
03
OMDA
OMADA HEALTH INC
$56M2.5M16.9%
04
ZBIO
ZENAS BIOPHARMA INC
$47M1.8M14.2%
05
SNOW
SNOWFLAKE INC
$29M115K8.9%
06
GROV
GROVE COLLABORATIVE HOLD INC
$4M3.2M1.2%
07
ONDS
ONDAS INC
$129K16K0.0%

Filing history

2026Q2Jun 30
$328M 28.6%
7 positionsView →
2025Q4Dec 31
$255M 53.7%
6 positionsView →
2025Q3Sep 30
$166M 9.8%
5 positionsView →
2025Q2Jun 30
$184M 70.7%
7 positionsLocked
2025Q1Mar 31
$108M 42.3%
5 positionsLocked
2024Q4Dec 31
$187M 6.1%
7 positionsLocked
2024Q3Sep 30
$176M 93.0%
8 positionsLocked
2024Q2Jun 30
$91M 27.5%
6 positionsLocked
2024Q1Mar 31
$126M 12.4%
6 positionsLocked
2023Q4Dec 31
$112M 0.4%
6 positionsLocked
2023Q3Sep 30
$112M 2.6%
8 positionsLocked
2023Q2Jun 30
$115M 31.9%
9 positionsLocked
Showing 12 of 14